Birdwatch Archive

Birdwatch Note

2024-01-07 14:42:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Die Cochrane Studie findet eine RR von 1.01 für die Effektivität von Masken bei klinisch bestätigtem ILI/Covid. N95/FFP2 Masken habe im Vergleich zu OP Masken eine RR von 1.10. Diese Werte deuten auf keinen Nutzen von Masken hin, aber die Aussagekraft ist limitiert. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006207.pub6/full

Written by 3E8409710391E5AF9D4765FB49995766E8A5A9027CA8AB84E1892E610C4A5976
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1743925081578094933

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1744006479579951184
  • noteId - 1744006479579951184
  • participantId -
  • noteAuthorParticipantId - 3E8409710391E5AF9D4765FB49995766E8A5A9027CA8AB84E1892E610C4A5976 Participant Details
  • createdAtMillis - 1704638521458
  • tweetId - 1743925081578094933
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Die Cochrane Studie findet eine RR von 1.01 für die Effektivität von Masken bei klinisch bestätigtem ILI/Covid. N95/FFP2 Masken habe im Vergleich zu OP Masken eine RR von 1.10. Diese Werte deuten auf keinen Nutzen von Masken hin, aber die Aussagekraft ist limitiert. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006207.pub6/full

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-01-07 14:42:01 UTC
(1704638521458)
2024-01-07 17:06:03 UTC
(1704647163950)
CURRENTLY_RATED_NOT_HELPFUL 2024-01-08 02:01:53 UTC
(1704679313262)
NEEDS_MORE_RATINGS 2024-01-07 17:06:03 UTC
(1704647163950)
CURRENTLY_RATED_NOT_HELPFUL

Note Ratings

rated at rated by
2024-01-07 18:44:13 -0600 Rating Details
2024-01-07 17:56:22 -0600 Rating Details
2024-01-07 16:40:33 -0600 Rating Details
2024-01-07 16:23:02 -0600 Rating Details
2024-01-07 16:09:21 -0600 Rating Details
2024-01-07 16:06:12 -0600 Rating Details
2024-01-07 15:40:56 -0600 Rating Details
2024-01-07 15:36:06 -0600 Rating Details
2024-01-07 15:25:12 -0600 Rating Details
2024-01-07 13:25:01 -0600 Rating Details
2024-01-07 13:23:35 -0600 Rating Details
2024-01-07 13:06:02 -0600 Rating Details
2024-01-07 13:04:16 -0600 Rating Details
2024-01-07 12:40:29 -0600 Rating Details
2024-01-07 12:34:10 -0600 Rating Details
2024-01-07 12:33:23 -0600 Rating Details
2024-01-07 11:18:43 -0600 Rating Details
2024-01-07 11:01:17 -0600 Rating Details
2024-01-07 10:47:21 -0600 Rating Details
2024-01-07 10:45:50 -0600 Rating Details
2024-01-07 10:13:35 -0600 Rating Details
2024-01-07 09:18:03 -0600 Rating Details
2024-01-07 08:53:49 -0600 Rating Details
2024-01-08 15:11:44 -0600 Rating Details
2024-01-08 03:41:16 -0600 Rating Details
2024-01-08 02:32:02 -0600 Rating Details
2024-01-08 01:48:58 -0600 Rating Details
2024-01-08 01:34:33 -0600 Rating Details
2024-01-08 00:20:08 -0600 Rating Details
2024-01-07 20:29:51 -0600 Rating Details
2024-01-09 01:41:42 -0600 Rating Details
2024-01-08 10:30:07 -0600 Rating Details
2024-01-08 03:27:38 -0600 Rating Details
2024-01-08 03:02:13 -0600 Rating Details
2024-01-08 02:11:20 -0600 Rating Details
2024-01-07 23:50:53 -0600 Rating Details
2024-01-07 22:59:03 -0600 Rating Details